Mirati Therapeutics, Inc. (MRTX)
(Delayed Data from NSDQ)
$63.93 USD
+2.52 (4.10%)
Updated May 3, 2019 04:00 PM ET
After-Market: $64.05 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For MRTX
-
Mirati (MRTX) Up 1.1% Since Last Earnings Report: Can It Continue?
-
Mirati's (MRTX) Q3 Loss Narrows, Sales Miss Expectations
-
Mirati Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Updates
-
Mirati: Q3 Earnings Snapshot
-
Mirati (MRTX) Q2 Earnings Beat, Stock Up on Solid Krazati Sales
-
Mirati (MRTX) Reports Q2 Loss, Misses Revenue Estimates
-
Mirati: Q2 Earnings Snapshot
-
Mirati Therapeutics Reports Second Quarter 2023 Financial Results and Recent Corporate Updates
-
Mirati (MRTX) Down 17.6% Since Last Earnings Report: Can It Rebound?
-
Mirati (MRTX) Q1 Earnings & Revenues Beat Estimates, Stock Up
-
Mirati (MRTX) Reports Q1 Loss, Tops Revenue Estimates
-
Mirati: Q1 Earnings Snapshot
-
Mirati Therapeutics Reports First Quarter 2023 Financial Results and Recent Corporate Updates
-
Mirati (MRTX) Down 16.1% Since Last Earnings Report: Can It Rebound?
-
Mirati's (MRTX) Q4 Loss Narrows, Krazati Records First Sales
-
Mirati: Q4 Earnings Snapshot
-
Mirati (MRTX) Reports Q4 Loss, Misses Revenue Estimates
-
Mirati Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Updates
-
Why Is Mirati (MRTX) Down 19.9% Since Last Earnings Report?
-
Mirati's (MRTX) Stock Rises on Q3 Earnings and Sales Beat
-
Mirati: Q3 Earnings Snapshot
-
Mirati (MRTX) Reports Q3 Loss, Tops Revenue Estimates
-
Mirati Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Updates
-
Mirati (MRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
-
Mirati (MRTX) Up 5.3% Since Last Earnings Report: Can It Continue?